APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Marburg Hemorrhagic Fever Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Marburg Hemorrhagic Fever Drug Market Outlook and Growth Opportunities 2026

Report ID 174010180419 December 2025197 pages

Choose your research edition.

Industry ResearchMarburg Hemorrhagic Fever Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Marburg Hemorrhagic Fever Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Marburg Hemorrhagic Fever Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marburg Hemorrhagic Fever Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marburg Hemorrhagic Fever Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Marburg Hemorrhagic Fever Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Marburg Hemorrhagic Fever Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Marburg Hemorrhagic Fever Drug market include GlaxoSmithKline plc, Vaxart, Inc, Tekmira Pharmaceuticals Corp., Sarepta Therapeutics, Inc., Integrated BioTherapeutics, Inc. and Immunovaccine, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Marburg Hemorrhagic Fever Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Marburg Hemorrhagic Fever Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Marburg Hemorrhagic Fever Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marburg Hemorrhagic Fever Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Marburg Hemorrhagic Fever Drug Segment by Company

GlaxoSmithKline plc

Vaxart, Inc

Tekmira Pharmaceuticals Corp.

Sarepta Therapeutics, Inc.

Integrated BioTherapeutics, Inc.

Immunovaccine, Inc.

Marburg Hemorrhagic Fever Drug Segment by Type

TKM-Marburg

Marburg Vaccine

AVI-7288

Others

Marburg Hemorrhagic Fever Drug Segment by Application

Clinic

Hospital

Others

Marburg Hemorrhagic Fever Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Marburg Hemorrhagic Fever Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Marburg Hemorrhagic Fever Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Marburg Hemorrhagic Fever Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Marburg Hemorrhagic Fever Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marburg Hemorrhagic Fever Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marburg Hemorrhagic Fever Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marburg Hemorrhagic Fever Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Marburg Hemorrhagic Fever Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marburg Hemorrhagic Fever Drug industry.

Chapter 3: Detailed analysis of Marburg Hemorrhagic Fever Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Marburg Hemorrhagic Fever Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Marburg Hemorrhagic Fever Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Marburg Hemorrhagic Fever Drug Industry Trends Table 2. Marburg Hemorrhagic Fever Drug Industry Drivers Table 3. Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges Table 4. Marburg Hemorrhagic Fever Drug Industry Restraints Table 5. Global Marburg Hemorrhagic Fever Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Marburg Hemorrhagic Fever Drug Revenue Share by Company (2021-2026) Table 7. Global Marburg Hemorrhagic Fever Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Company (2021-2026) Table 9. Global Marburg Hemorrhagic Fever Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Marburg Hemorrhagic Fever Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Marburg Hemorrhagic Fever Drug Key Company Manufacturing Base & Headquarters Table 12. Global Marburg Hemorrhagic Fever Drug Company, Product Type & Application Table 13. Global Marburg Hemorrhagic Fever Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Marburg Hemorrhagic Fever Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of TKM-Marburg Table 18. Significant Companies of Marburg Vaccine Table 19. Significant Companies of AVI-7288 Table 20. Significant Companies of Others Table 21. Global Marburg Hemorrhagic Fever Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Marburg Hemorrhagic Fever Drug Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Marburg Hemorrhagic Fever Drug Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Type (2021-2026) Table 25. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Type (2027-2032) Table 26. Global Marburg Hemorrhagic Fever Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Marburg Hemorrhagic Fever Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Marburg Hemorrhagic Fever Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Type (2021-2026) Table 30. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Others Table 34. Global Marburg Hemorrhagic Fever Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Marburg Hemorrhagic Fever Drug Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Marburg Hemorrhagic Fever Drug Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Application (2021-2026) Table 38. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Application (2027-2032) Table 39. Global Marburg Hemorrhagic Fever Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Marburg Hemorrhagic Fever Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Marburg Hemorrhagic Fever Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Application (2021-2026) Table 43. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Application (2027-2032) Table 44. Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2021-2026) Table 47. Global Marburg Hemorrhagic Fever Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2027-2032) Table 49. Global Marburg Hemorrhagic Fever Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Marburg Hemorrhagic Fever Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Region (2021-2026) Table 52. Global Marburg Hemorrhagic Fever Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Region (2027-2032) Table 54. Global Marburg Hemorrhagic Fever Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Marburg Hemorrhagic Fever Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Marburg Hemorrhagic Fever Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 59. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 60. Global Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2027-2032) Table 62. Global Marburg Hemorrhagic Fever Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Marburg Hemorrhagic Fever Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Marburg Hemorrhagic Fever Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Marburg Hemorrhagic Fever Drug Sales Value Market Share by Country (2027-2032) Table 66. GlaxoSmithKline plc Company Information Table 67. GlaxoSmithKline plc Business Overview Table 68. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio Table 70. GlaxoSmithKline plc Recent Development Table 71. Vaxart, Inc Company Information Table 72. Vaxart, Inc Business Overview Table 73. Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio Table 75. Vaxart, Inc Recent Development Table 76. Tekmira Pharmaceuticals Corp. Company Information Table 77. Tekmira Pharmaceuticals Corp. Business Overview Table 78. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio Table 80. Tekmira Pharmaceuticals Corp. Recent Development Table 81. Sarepta Therapeutics, Inc. Company Information Table 82. Sarepta Therapeutics, Inc. Business Overview Table 83. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 85. Sarepta Therapeutics, Inc. Recent Development Table 86. Integrated BioTherapeutics, Inc. Company Information Table 87. Integrated BioTherapeutics, Inc. Business Overview Table 88. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 90. Integrated BioTherapeutics, Inc. Recent Development Table 91. Immunovaccine, Inc. Company Information Table 92. Immunovaccine, Inc. Business Overview Table 93. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 95. Immunovaccine, Inc. Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Marburg Hemorrhagic Fever Drug Distributors List Table 99. Marburg Hemorrhagic Fever Drug Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Marburg Hemorrhagic Fever Drug Product Image Figure 2. Global Marburg Hemorrhagic Fever Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Marburg Hemorrhagic Fever Drug Sales (2021-2032) & (K Units) Figure 5. Global Marburg Hemorrhagic Fever Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Marburg Hemorrhagic Fever Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. TKM-Marburg Image Figure 10. Marburg Vaccine Image Figure 11. AVI-7288 Image Figure 12. Others Image Figure 13. Global Marburg Hemorrhagic Fever Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Marburg Hemorrhagic Fever Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Marburg Hemorrhagic Fever Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Marburg Hemorrhagic Fever Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global Marburg Hemorrhagic Fever Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Marburg Hemorrhagic Fever Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Marburg Hemorrhagic Fever Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Marburg Hemorrhagic Fever Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Application (2021-2032) Figure 28. Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Marburg Hemorrhagic Fever Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Marburg Hemorrhagic Fever Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Marburg Hemorrhagic Fever Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Marburg Hemorrhagic Fever Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Marburg Hemorrhagic Fever Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Marburg Hemorrhagic Fever Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Marburg Hemorrhagic Fever Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Marburg Hemorrhagic Fever Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Marburg Hemorrhagic Fever Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • TKM-Marburg
  • Marburg Vaccine
  • AVI-7288
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • GlaxoSmithKline plc
  • Vaxart, Inc
  • Tekmira Pharmaceuticals Corp.
  • Sarepta Therapeutics, Inc.
  • Integrated BioTherapeutics, Inc.
  • Immunovaccine, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  4. 1.2.2 Global Marburg Hemorrhagic Fever Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Marburg Hemorrhagic Fever Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Marburg Hemorrhagic Fever Drug Market Dynamics
  1. 2.1 Marburg Hemorrhagic Fever Drug Industry Trends
  2. 2.2 Marburg Hemorrhagic Fever Drug Industry Drivers
  3. 2.3 Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges
  4. 2.4 Marburg Hemorrhagic Fever Drug Industry Restraints
3 Marburg Hemorrhagic Fever Drug Market by Company
  1. 3.1 Global Marburg Hemorrhagic Fever Drug Company Revenue Ranking in 2025
  2. 3.2 Global Marburg Hemorrhagic Fever Drug Revenue by Company (2021-2026)
  3. 3.3 Global Marburg Hemorrhagic Fever Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Marburg Hemorrhagic Fever Drug Average Price by Company (2021-2026)
  5. 3.5 Global Marburg Hemorrhagic Fever Drug Company Ranking (2024-2026)
  6. 3.6 Global Marburg Hemorrhagic Fever Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Marburg Hemorrhagic Fever Drug Company Product Type and Application
  8. 3.8 Global Marburg Hemorrhagic Fever Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Marburg Hemorrhagic Fever Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Marburg Hemorrhagic Fever Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Marburg Hemorrhagic Fever Drug Market by Type
  1. 4.1 Marburg Hemorrhagic Fever Drug Type Introduction
  2. 4.1.1 TKM-Marburg
  3. 4.1.2 Marburg Vaccine
  4. 4.1.3 AVI-7288
  5. 4.1.4 Others
  6. 4.2 Global Marburg Hemorrhagic Fever Drug Sales Volume by Type
  7. 4.2.1 Global Marburg Hemorrhagic Fever Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Marburg Hemorrhagic Fever Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Marburg Hemorrhagic Fever Drug Sales Value by Type
  11. 4.3.1 Global Marburg Hemorrhagic Fever Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Marburg Hemorrhagic Fever Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Marburg Hemorrhagic Fever Drug Sales Value Share by Type (2021-2032)
5 Marburg Hemorrhagic Fever Drug Market by Application
  1. 5.1 Marburg Hemorrhagic Fever Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Marburg Hemorrhagic Fever Drug Sales Volume by Application
  6. 5.2.1 Global Marburg Hemorrhagic Fever Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Marburg Hemorrhagic Fever Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Marburg Hemorrhagic Fever Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Marburg Hemorrhagic Fever Drug Sales Value by Application
  10. 5.3.1 Global Marburg Hemorrhagic Fever Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Marburg Hemorrhagic Fever Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Marburg Hemorrhagic Fever Drug Sales Value Share by Application (2021-2032)
6 Marburg Hemorrhagic Fever Drug Regional Sales and Value Analysis
  1. 6.1 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Marburg Hemorrhagic Fever Drug Sales by Region (2027-2032)
  5. 6.3 Global Marburg Hemorrhagic Fever Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Marburg Hemorrhagic Fever Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Marburg Hemorrhagic Fever Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Marburg Hemorrhagic Fever Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Marburg Hemorrhagic Fever Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  12. 6.6.2 North America Marburg Hemorrhagic Fever Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Marburg Hemorrhagic Fever Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  21. 6.9.2 South America Marburg Hemorrhagic Fever Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Marburg Hemorrhagic Fever Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Marburg Hemorrhagic Fever Drug Sales Value Share by Country, 2025 VS 2032
7 Marburg Hemorrhagic Fever Drug Country-level Sales and Value Analysis
  1. 7.1 Global Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Marburg Hemorrhagic Fever Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Marburg Hemorrhagic Fever Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Marburg Hemorrhagic Fever Drug Sales by Country (2027-2032)
  6. 7.4 Global Marburg Hemorrhagic Fever Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Marburg Hemorrhagic Fever Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Marburg Hemorrhagic Fever Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Marburg Hemorrhagic Fever Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Marburg Hemorrhagic Fever Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Marburg Hemorrhagic Fever Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline plc
  2. 8.1.1 GlaxoSmithKline plc Company Information
  3. 8.1.2 GlaxoSmithKline plc Business Overview
  4. 8.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio
  6. 8.1.5 GlaxoSmithKline plc Recent Developments
  7. 8.2 Vaxart, Inc
  8. 8.2.1 Vaxart, Inc Company Information
  9. 8.2.2 Vaxart, Inc Business Overview
  10. 8.2.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio
  12. 8.2.5 Vaxart, Inc Recent Developments
  13. 8.3 Tekmira Pharmaceuticals Corp.
  14. 8.3.1 Tekmira Pharmaceuticals Corp. Company Information
  15. 8.3.2 Tekmira Pharmaceuticals Corp. Business Overview
  16. 8.3.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio
  18. 8.3.5 Tekmira Pharmaceuticals Corp. Recent Developments
  19. 8.4 Sarepta Therapeutics, Inc.
  20. 8.4.1 Sarepta Therapeutics, Inc. Company Information
  21. 8.4.2 Sarepta Therapeutics, Inc. Business Overview
  22. 8.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  24. 8.4.5 Sarepta Therapeutics, Inc. Recent Developments
  25. 8.5 Integrated BioTherapeutics, Inc.
  26. 8.5.1 Integrated BioTherapeutics, Inc. Company Information
  27. 8.5.2 Integrated BioTherapeutics, Inc. Business Overview
  28. 8.5.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  30. 8.5.5 Integrated BioTherapeutics, Inc. Recent Developments
  31. 8.6 Immunovaccine, Inc.
  32. 8.6.1 Immunovaccine, Inc. Company Information
  33. 8.6.2 Immunovaccine, Inc. Business Overview
  34. 8.6.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  36. 8.6.5 Immunovaccine, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Marburg Hemorrhagic Fever Drug Value Chain Analysis
  2. 9.1.1 Marburg Hemorrhagic Fever Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Marburg Hemorrhagic Fever Drug Sales Mode & Process
  6. 9.2 Marburg Hemorrhagic Fever Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Marburg Hemorrhagic Fever Drug Distributors
  9. 9.2.3 Marburg Hemorrhagic Fever Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst